Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALT |
---|---|---|
09:32 ET | 23786 | 6.2015 |
09:34 ET | 22600 | 6.143 |
09:36 ET | 3906 | 6.156416 |
09:38 ET | 7275 | 6.18 |
09:39 ET | 2519 | 6.165 |
09:41 ET | 10480 | 6.1778 |
09:43 ET | 8033 | 6.15 |
09:45 ET | 66881 | 6.13 |
09:48 ET | 2500 | 6.12 |
09:50 ET | 19812 | 6.145 |
09:52 ET | 871 | 6.16 |
09:54 ET | 5605 | 6.16 |
09:56 ET | 9766 | 6.145 |
09:57 ET | 7449 | 6.14 |
09:59 ET | 5850 | 6.146 |
10:01 ET | 10359 | 6.1499 |
10:03 ET | 3831 | 6.1755 |
10:06 ET | 3393 | 6.18 |
10:08 ET | 7744 | 6.165 |
10:10 ET | 7658 | 6.215 |
10:12 ET | 4450 | 6.19 |
10:14 ET | 1868 | 6.23 |
10:15 ET | 1299 | 6.2129 |
10:17 ET | 1786 | 6.2072 |
10:19 ET | 2464 | 6.21 |
10:21 ET | 700 | 6.2299 |
10:24 ET | 2118 | 6.19 |
10:26 ET | 2779 | 6.2 |
10:28 ET | 1384 | 6.2 |
10:30 ET | 8931 | 6.2199 |
10:32 ET | 730 | 6.2 |
10:33 ET | 5813 | 6.2301 |
10:35 ET | 7378 | 6.25 |
10:37 ET | 15347 | 6.24 |
10:39 ET | 3477 | 6.225 |
10:42 ET | 3761 | 6.225 |
10:44 ET | 2626 | 6.26 |
10:46 ET | 4042 | 6.255 |
10:48 ET | 1880 | 6.26 |
10:50 ET | 7070 | 6.27 |
10:51 ET | 4258 | 6.27 |
10:53 ET | 5409 | 6.27 |
10:55 ET | 1069 | 6.25 |
10:57 ET | 3950 | 6.24 |
11:00 ET | 3900 | 6.24 |
11:02 ET | 2801 | 6.26 |
11:04 ET | 5783 | 6.2777 |
11:06 ET | 23055 | 6.309 |
11:08 ET | 5247 | 6.3 |
11:09 ET | 5004 | 6.25 |
11:11 ET | 5604 | 6.23 |
11:13 ET | 1782 | 6.24 |
11:15 ET | 7579 | 6.22 |
11:18 ET | 2363 | 6.24 |
11:20 ET | 1780 | 6.265 |
11:22 ET | 3446 | 6.275 |
11:24 ET | 8011 | 6.26 |
11:26 ET | 1884 | 6.25 |
11:27 ET | 1323 | 6.23 |
11:29 ET | 549 | 6.24 |
11:31 ET | 400 | 6.24 |
11:33 ET | 2048 | 6.22 |
11:36 ET | 1306 | 6.2467 |
11:38 ET | 752 | 6.2576 |
11:40 ET | 3411 | 6.25 |
11:42 ET | 493 | 6.2521 |
11:44 ET | 2037 | 6.265 |
11:45 ET | 100 | 6.26 |
11:47 ET | 1200 | 6.253 |
11:49 ET | 2351 | 6.2601 |
11:51 ET | 500 | 6.26 |
11:54 ET | 1300 | 6.26 |
11:56 ET | 1300 | 6.265 |
11:58 ET | 2315 | 6.28 |
12:00 ET | 1340 | 6.265 |
12:02 ET | 400 | 6.27 |
12:03 ET | 15900 | 6.3 |
12:05 ET | 5986 | 6.27 |
12:07 ET | 1660 | 6.275 |
12:09 ET | 765 | 6.275 |
12:12 ET | 3600 | 6.275 |
12:14 ET | 2210 | 6.285 |
12:16 ET | 33395 | 6.28 |
12:18 ET | 1600 | 6.255 |
12:20 ET | 3700 | 6.2373 |
12:21 ET | 1700 | 6.24 |
12:23 ET | 1500 | 6.245 |
12:25 ET | 1996 | 6.26 |
12:27 ET | 1400 | 6.2575 |
12:30 ET | 2626 | 6.255 |
12:32 ET | 4270 | 6.23 |
12:34 ET | 10199 | 6.2496 |
12:36 ET | 4600 | 6.23 |
12:38 ET | 14511 | 6.225 |
12:39 ET | 4342 | 6.2158 |
12:41 ET | 2309 | 6.215 |
12:43 ET | 14150 | 6.2 |
12:45 ET | 10281 | 6.17 |
12:48 ET | 7335 | 6.16 |
12:50 ET | 2977 | 6.16 |
12:52 ET | 16795 | 6.14 |
12:54 ET | 3510 | 6.15 |
12:56 ET | 2426 | 6.14 |
12:57 ET | 30416 | 6.12 |
12:59 ET | 12570 | 6.1 |
01:01 ET | 6804 | 6.1 |
01:03 ET | 8017 | 6.0997 |
01:06 ET | 5737 | 6.12 |
01:08 ET | 13855 | 6.15 |
01:10 ET | 3428 | 6.13 |
01:12 ET | 8130 | 6.135 |
01:14 ET | 3862 | 6.125 |
01:15 ET | 2698 | 6.13 |
01:17 ET | 1904 | 6.145 |
01:19 ET | 9140 | 6.145 |
01:21 ET | 1041 | 6.15 |
01:24 ET | 1700 | 6.15 |
01:26 ET | 5214 | 6.15 |
01:28 ET | 3105 | 6.155 |
01:30 ET | 2121 | 6.165 |
01:32 ET | 500 | 6.15 |
01:33 ET | 882 | 6.145 |
01:35 ET | 10131 | 6.13 |
01:37 ET | 4103 | 6.135 |
01:39 ET | 5835 | 6.145 |
01:42 ET | 2000 | 6.16 |
01:44 ET | 476 | 6.15 |
01:46 ET | 5436 | 6.16 |
01:48 ET | 2860 | 6.17 |
01:50 ET | 16100 | 6.17 |
01:51 ET | 1102 | 6.175 |
01:53 ET | 1555 | 6.195 |
01:55 ET | 2494 | 6.21 |
01:57 ET | 6757 | 6.185 |
02:00 ET | 806 | 6.195 |
02:02 ET | 1943 | 6.2 |
02:04 ET | 1900 | 6.19 |
02:06 ET | 1100 | 6.1925 |
02:08 ET | 6900 | 6.185 |
02:09 ET | 2535 | 6.18 |
02:11 ET | 4951 | 6.19 |
02:13 ET | 11368 | 6.23 |
02:15 ET | 5616 | 6.2129 |
02:18 ET | 350 | 6.215 |
02:20 ET | 2086 | 6.215 |
02:22 ET | 4881 | 6.22 |
02:24 ET | 1349 | 6.227 |
02:26 ET | 5300 | 6.225 |
02:27 ET | 15944 | 6.235 |
02:29 ET | 5366 | 6.21 |
02:31 ET | 1248 | 6.225 |
02:33 ET | 1400 | 6.24 |
02:36 ET | 400 | 6.245 |
02:38 ET | 1600 | 6.245 |
02:40 ET | 1500 | 6.2343 |
02:42 ET | 1600 | 6.235 |
02:44 ET | 1700 | 6.24 |
02:45 ET | 2394 | 6.23 |
02:47 ET | 17226 | 6.24 |
02:49 ET | 2450 | 6.24 |
02:51 ET | 2500 | 6.22 |
02:54 ET | 7736 | 6.1901 |
02:56 ET | 3300 | 6.21 |
02:58 ET | 2479 | 6.215 |
03:00 ET | 4540 | 6.21 |
03:02 ET | 2789 | 6.2199 |
03:03 ET | 5461 | 6.225 |
03:05 ET | 2674 | 6.235 |
03:07 ET | 2202 | 6.23 |
03:09 ET | 2992 | 6.24 |
03:12 ET | 1919 | 6.235 |
03:14 ET | 9716 | 6.245 |
03:16 ET | 6094 | 6.26 |
03:18 ET | 4900 | 6.27 |
03:20 ET | 13515 | 6.285 |
03:21 ET | 1140 | 6.28 |
03:23 ET | 8970 | 6.285 |
03:25 ET | 6000 | 6.285 |
03:27 ET | 4556 | 6.2799 |
03:30 ET | 2946 | 6.285 |
03:32 ET | 1147 | 6.275 |
03:34 ET | 985 | 6.2662 |
03:36 ET | 25414 | 6.2601 |
03:38 ET | 33721 | 6.295 |
03:39 ET | 23422 | 6.266 |
03:41 ET | 2326 | 6.26 |
03:43 ET | 3392 | 6.285 |
03:45 ET | 17094 | 6.28 |
03:48 ET | 23157 | 6.29 |
03:50 ET | 2454 | 6.275 |
03:52 ET | 5949 | 6.265 |
03:54 ET | 5881 | 6.255 |
03:56 ET | 3073 | 6.27 |
03:57 ET | 13376 | 6.265 |
03:59 ET | 140530 | 6.27 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Altimmune Inc | 445.6M | -3.9x | --- |
Mind Medicine (MindMed) Inc | 446.5M | -2.5x | --- |
Tectonic Therapeutic Inc | 441.7M | -1.6x | --- |
Aura Biosciences Inc | 433.6M | -4.9x | --- |
PureTech Health PLC | 452.3M | -6.4x | --- |
ProKidney Corp | 476.5M | -2.8x | --- |
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. The Company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). The Company has completed the MOMENTUM Phase II obesity trial and is being studied in the IMPACT Phase IIb MASH trial. It is also developing HepTcell, an immunotherapeutic product candidate for patients chronically infected with the hepatitis B virus (HBV). The Company has completed the enrollment in its Phase II clinical trial of HepTcell. Its product candidates are based on its proprietary platform technologies, such as EuPort-based Peptide Technology and Synthetic Peptide Technology-Densigen. The Company’s wholly owned subsidiaries include Altimmune, LLC, Altimmune UK, Limited, Spitfire Pharma, LLC and Altimmune AU Pty, Limited.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $445.6M |
---|---|
Revenue (TTM) | $409.0K |
Shares Outstanding | 71.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.08 |
EPS | $-1.62 |
Book Value | $2.75 |
P/E Ratio | -3.9x |
Price/Sales (TTM) | 1,089.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -26,822.01% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.